4.4 Article

Immunologic aspects of monoclonal B-cell lymphocytosis

Journal

IMMUNOLOGIC RESEARCH
Volume 49, Issue 1-3, Pages 269-280

Publisher

HUMANA PRESS INC
DOI: 10.1007/s12026-010-8188-4

Keywords

Monoclonal B lymphocytosis; Chronic lymphocytic leukemia; Non-Hodgkin's lymphoma; B-cell receptor; B-cell development

Categories

Funding

  1. Leukemia and Lymphoma Society of America
  2. Bernstein Fund for Leukemia Research
  3. VA Research Service
  4. National Institutes of Health [NCI R03 CA128030, CA118444, CA92153]
  5. National Cancer Institute [CA15083]
  6. CLL Research Consortium

Ask authors/readers for more resources

Monoclonal B-cell lymphocytosis (MBL) is a preclinical hematologic condition wherein small numbers of clonal B cells can be detected in the blood of otherwise healthy individuals. Most MBL have a surface immunophenotype nearly identical to that of chronic lymphocytic leukemia (CLL), though other phenotypes can also be identified. MBL has been shown to be a precursor state for CLL, but most MBL clones are quite small and apparently have minimal potential to progress of CLL or other B-cell lymphoproliferative disorder (B-LPD). The investigation of MBL as a precursor state for CLL will likely lead to important insights into mechanisms of disease pathogenesis. The review will cover clinical and translational aspects of MBL, with a particular emphasis on the prevalence of MBL; the relationship between MBL, CLL, and other B-LPDs; and the capacity of MBL to modulate the normal B- and T-cell compartments.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available